1.
The Chinese Native Place Manufactures Drugs the Enterprise New Medicine Research Development Development Research;
中国本土制药企业新药研究开发发展的研究
2.
Strategical Consideration about Research and Development of New Veterinary Drugs;
关于我国新兽药研究开发的战略思考
3.
Retrospection,stratagem,and practice on innovative drug research and development of Chinese materia medica
中药创新药物研究开发的回顾、策略与实践
4.
Development and Utilization of Information Resources for New Drug R&D;
新药研发信息资源开发与利用的策略研究
5.
The international technical requirements on the preclinical toxicity studies and the inspirations to the R&D of new drugs in China
国际新药临床前毒理学研究要求及对中国新药开发的启示
6.
Studies on the Chemical Constituents of Ranunculus Japonicus;
毛茛化学成分的研究及几种中药新药的开发研究
7.
Application of Drug Metabolism and Pharmacokinetics Evaluation in Drug Discovery and Development;
药物代谢动力学性质评价在新药发现及开发中的应用研究
8.
The Marketing Strategy of Shanghai YS New Drug Exploration Limited Company;
上海YS新药开发有限公司营销策略研究
9.
The Research of a New Drug of the Anti-inflammatory and Relieving Itching Gel That Can be Used to the Treatment of the Chronic Eczema
治疗慢性湿疹新药消炎止痒凝胶的开发研究
10.
Structural Diversity and Structure-Activity Relationship--New Drug Research and Development of Tripterygium wilfordii Hook.f.
结构多样性与构效关系——雷公藤新药研究与开发
11.
Clinical Development and Research of Treating Jaundice for Newborn by Chinese Herbal Lotion(Tui Huang Xi Ye)
新生儿退黄中药外洗液的临床开发研究
12.
Reserach and Development of Microbiological Medicines and Chemical Reagents
微生物药品研究与开发
13.
A Deliberation on Methodology of Modernization of Traditional Chinese Medicines Based on the Research and Development of New Drugs from "Cao Wu"
从草乌化学研究开发的新药思考中药现代化的方法
14.
China s Pharmaceutical Pricing on the Impact of New Drug Research and Development;
我国药品定价对新药研发的影响研究
15.
Research of Chinese Pharmaceutical Enterprise Novel Drug Development Strategy;
我国制药企业创新药物研发战略研究
16.
New paradigm of accelerating new drug development--microdosing
加速药物研发新方式——微剂量给药研究
17.
Article 4 The State shall encourage the research and production of new medicine and protect the legal rights and interests of its citizens, natural persons and other organizations in the research and development of new medicine.
第四条国家鼓励研究和创制新药，保护公民、法人和其他组织研究、开发新药的合法权益。
18.
The Research on Biopharmaceutical Innovation Mechanism of Harbin Pharmaceutical Group
哈药集团发展生物制药创新机制研究